Response

J Natl Cancer Inst. 2014 Sep 15;106(10):dju272. doi: 10.1093/jnci/dju272. Print 2014 Oct.

Authors

Willemien van de Water¹, Mandy Kiderlen², Esther Bastiaannet², Rudi G J Westendorp², C J H van de Velde², Anton J M de Craen², Gerrit-Jan Liefers²

Affiliations

¹ Department of Surgical Oncology (WvdW, MK, EB, CJHvdV, GJL) and Department of Geriatrics and Gerontology (WvdW, EB, RGJW, AJMdC), Leiden University Medical Center. [email protected].
² Department of Surgical Oncology (WvdW, MK, EB, CJHvdV, GJL) and Department of Geriatrics and Gerontology (WvdW, EB, RGJW, AJMdC), Leiden University Medical Center.

PMID: 25224498
DOI: 10.1093/jnci/dju272

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Biomarkers, Tumor / analysis*
Breast Neoplasms / drug therapy*
Breast Neoplasms / mortality*
Female
Humans

Substances

Biomarkers, Tumor